Table 2. Unifactorial analysis of demographic and clinical characteristics in relation to FAK positivity and IRS score.
All categorical variables were presented as frequencies (%). FAK: focal adhesion kinase, IRS: immunoreactive score.
| Variables | FAK positivity | p-value | FAK IRS score | p-value | |||
| Negative (n=40) | Positive (n=50) | No (n=51) | Weak-moderate (n=39) | ||||
| Age; mean ± SD | 60.03 ± 11.96 | 59.90 ± 13.83 | 0.964 | 60.18 ± 12.03 | 59.67 ± 14.24 | 0.854 | |
| Histologic type | Clear cell | 33 (56.9) | 25 (43.1) | <0.005 | 40 (69.0) | 18 (31.0) | <0.005 |
| Papillary | 2 (13.3) | 13 (86.7) | 4 (26.7) | 11 (73.3) | |||
| Chromophobe | 2 (18.2) | 9 (81.8) | 4 (36.4) | 7 (63.6) | |||
| Grade | 1 | 6 (66.7) | 3 (33.3) | 0.234 | 6 (66.7) | 3 (33.3) | 0.074 |
| 2 | 21 (46.7) | 24 (53.3) | 30 (66.7) | 15 (33.3) | |||
| 3 and 4 | 13 (36.1) | 23 (63.9) | 15 (41.7) | 21 (58.3) | |||
| Gender | Male | 29 (46) | 34 (54) | 0.817 | 13 (48.1) | 14 (51.9) | 0.355 |
| Female | 11 (40.7) | 16 (59.3) | 38 (60.3) | 25 (39.7) | |||
| Stage Τ | 1 | 28 (44.4) | 35 (55.6) | 0.996 | 36 (57.1) | 27 (42.9) | 0.774 |
| 2 | 5 (45.5) | 6 (54.5) | 7 (63.6) | 4 (36.4) | |||
| 3 | 7 (43.8) | 9 (56.3) | 8 (50) | 8 (50) | |||